Skip to content

DOCTEURS LEDUC KESTEMAN

Active
Private limited companyfounded 2021active for 5 yearsRue des Vennes 38, 4020 Liège, Belgium11 active companies are registered at this addressKBO/BCE: BE 0760.776.146

From the official registers: KBO 5 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

DOCTEURS LEDUC KESTEMAN has been active since 2021 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €6,578 and a net result of €112,578. Equity fluctuates too strongly from year to year to read a trend from it. Its solvency ranks better than 9% of 20,678 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).

Overview

Official details

KBO
Status
Active since 04-01-2021 Normal situation
Legal form
Private limited company
Registered office
Rue des Vennes 38, 4020 Liège
Activity
General medical practice NACE 86210
Establishment unit
2.311.880.875 4020 Liège, since 04-01-2021
Financial year end
31 December
Peppol
Reachable since 25-12-2025

Board and ownership

Financial position

89 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.2%
Annual accounts 2025
Gross margin
€215,654
▼ 24.7%
Turnover
≈ €400,000
estimated
Profit
€112,578
▼ 31.7%
Equity
€6,578
▲ 119%
Total assets
€178,546
▼ 36.5%
Staff
1 FTE
▼ 23.1%
2025 accounts filed 123 days before the deadline
Filed on 30-03-2026PDF
Score breakdownraises risk1 change of registered office in 24 monthsEquity €6,578 (3.7% of total assets)lowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 0.95, cash €45,608Show the evidence

Checked score

Score 2025
89 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 48% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Average
Solvency 29+3
equity 3.7% of total assets
Liquidity 40+11
short-term debt 76.9% · cash 25.5%
Profitability 100=
return on assets 63.1%
Bankruptcy probability within 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%

About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,155 companies, NACE 86, micro)
Last 24 months 11-2024: 0.2% 12-2024: < 0.1%▼ -0.2 percentage points vs 11-2024 01-2025: < 0.1%● unchanged vs 12-2024lowest value 02-2025: 0.1%▲ +0.1 percentage points vs 01-2025 03-2025: 0.1%● unchanged vs 02-2025 04-2025: 0.1%● unchanged vs 03-2025 05-2025: 0.1%● unchanged vs 04-2025 06-2025: 0.1%● unchanged vs 05-2025 07-2025: 0.1%● unchanged vs 06-2025 08-2025: 0.2%▲ +0.1 percentage points vs 07-2025 09-2025: 0.2%● unchanged vs 08-2025 10-2025: 0.2%● unchanged vs 09-2025 11-2025: 0.2%● unchanged vs 10-2025 12-2025: 0.2%● unchanged vs 11-2025 01-2026: 0.2%● unchanged vs 12-2025 02-2026: 0.2%● unchanged vs 01-2026 03-2026: 0.2%● unchanged vs 02-2026highest value 04-2026: 0.2%● unchanged vs 03-2026 05-2026: 0.2%● unchanged vs 04-2026 06-2026: 0.2%● unchanged vs 05-2026 07-2026: 0.2%● unchanged vs 06-2026 08-2026: 0.2%● unchanged vs 07-2026 09-2026: 0.2%● unchanged vs 08-2026 10-2026: 0.2%● unchanged vs 09-2026
Credit of up to €500 on 30-day terms is acceptable
Liquidity is insufficient, with a current ratio of 0.95 (1.0 in 2024), below 1. Short-term debt is 76.9% and cash 25.5% of total assets. 96.3% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 9% of them on solvency, 10% on liquidity, 80% on profitability and 92% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
raises risk · 1 change of registered office in 24 months
Belgian Official Gazette
lowers risk · Liquidity: current ratio 0.95, cash €45,608
NBB · annual accounts
raises risk · Equity €6,578 (3.7% of total assets)
NBB · annual accounts
raises risk · Weak solvency compared with the sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 9% of 20678 sector peers (2025).
NBB · sector comparison
Position among 20678 sector peers
Solvency
better than 9%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-03-2026, 123 days ahead of the deadline.
NBB · 5 filings
Deviation from the deadline
2025
123 days early
2024
2 days early
2023
110 days late
2022
7 days late
2021
23 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 5 accounts on average 3 days after the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 7 August (4 of the last 5 filed years within 104 days of that day).
Companies Code · seven months
Where today falls in the filing period
01-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Caution: Lower solvency than 91% of companies in human healthsector median 63.0% · 20,678 companies 3.7% View
  • Caution: Result fell in 2025from €164,805 to €112,578 ▼ 31.7% View
  • Positive: 5 profitable years in a rowprofit 2025: €112,578 5 years View

Documents

Annual accounts at the NBB

All 5 annual accounts

Articles and registers

Key facts about DOCTEURS LEDUC KESTEMAN

What is the company number of DOCTEURS LEDUC KESTEMAN?
The company number of DOCTEURS LEDUC KESTEMAN is 0760.776.146. The VAT number is the same number with BE in front: BE 0760.776.146.
Where is DOCTEURS LEDUC KESTEMAN based?
The registered office is at Rue des Vennes 38, 4020 Liège.Company details
What does DOCTEURS LEDUC KESTEMAN do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of DOCTEURS LEDUC KESTEMAN?
The legal form of DOCTEURS LEDUC KESTEMAN is Private limited company (BV).
When was DOCTEURS LEDUC KESTEMAN founded?
DOCTEURS LEDUC KESTEMAN was founded on 04-01-2021.
Is DOCTEURS LEDUC KESTEMAN still active?
Yes, DOCTEURS LEDUC KESTEMAN is an active enterprise in the KBO register.
How many employees does DOCTEURS LEDUC KESTEMAN have?
DOCTEURS LEDUC KESTEMAN had an average of 1 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of DOCTEURS LEDUC KESTEMAN?
The turnover in financial year 2025 is ≈ €400,000. This figure is estimated from the gross margin of €215,654 and 30 comparable companies (NACE 86210). It probably lies between €310,000 and €480,000.
Is DOCTEURS LEDUC KESTEMAN profitable?
In financial year 2025, DOCTEURS LEDUC KESTEMAN made a profit of €112,578.
Where can I find the annual accounts of DOCTEURS LEDUC KESTEMAN?
DOCTEURS LEDUC KESTEMAN filed 5 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts 2025 (PDF)
When are the next annual accounts of DOCTEURS LEDUC KESTEMAN due?
DOCTEURS LEDUC KESTEMAN must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Comparable companies

These companies have the same main activity as DOCTEURS LEDUC KESTEMAN: general medical practice (NACE 86210). They are comparable in size and age: total assets between €170,000 and €212,000, founded between 2020 and 2021.

CompanyTotal assetsGross margin
DOCTEURS LEDUC KESTEMAN Liège€178,546€215,654
CALUMETH Liège€212,262€211,212
DR. YULIYA SYZONENKO Retie€181,184€212,913
DR. BRAM DE WALSCHE Grobbendonk€169,636€220,719
DOTODOC Genk€203,786€218,134
Cabinet Médical du Docteur Tristan D'Andrea, médecin généraliste Hastière€169,691€199,744
Thunnus De Haan€180,193€193,896
Full comparison

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.